138 related articles for article (PubMed ID: 31598848)
1. Clinicopathological correlations of mesenteric fibrosis and evaluation of a novel biomarker for fibrosis detection in small bowel neuroendocrine neoplasms.
Laskaratos FM; Mandair D; Hall A; Alexander S; von Stempel C; Bretherton J; Luong T; Watkins J; Ogunbiyi O; Rombouts K; Caplin M; Toumpanakis C
Endocrine; 2020 Mar; 67(3):718-726. PubMed ID: 31598848
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of circulating transcript analysis (NETest) in small intestinal neuroendocrine neoplasms after surgical resection.
Laskaratos FM; Liu M; Malczewska A; Ogunbiyi O; Watkins J; Luong TV; Mandair D; Caplin M; Toumpanakis C
Endocrine; 2020 Aug; 69(2):430-440. PubMed ID: 32291735
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine Tumor Omic Gene Cluster Analysis Amplifies the Prognostic Accuracy of the NETest.
Kidd M; Kitz A; Drozdov I; Modlin I
Neuroendocrinology; 2021; 111(5):490-504. PubMed ID: 32392558
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of small intestinal neuroendocrine tumors and mesenteric fibrosis.
Blažević A; Iyer AM; van Velthuysen MF; Hofland J; Franssen GJH; Feelders RA; Zajec M; Luider TM; de Herder WW; Hofland LJ
Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36951556
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Clinical Prognostic Factors and Further Delineation of the Effect of Mesenteric Fibrosis on Survival in Advanced Midgut Neuroendocrine Tumours.
Laskaratos FM; Walker M; Wilkins D; Tuck A; Ramakrishnan S; Phillips E; Gertner J; Megapanou M; Papantoniou D; Shah R; Banks J; Vlachou E; Garcia-Hernandez J; Woodbridge L; Papadopoulou A; Grant L; Theocharidou E; Watkins J; Luong TV; Mandair D; Caplin M; Toumpanakis C
Neuroendocrinology; 2018; 107(3):292-304. PubMed ID: 30153671
[TBL] [Abstract][Full Text] [Related]
6. Mesenteric fibrosis in patients with small intestinal neuroendocrine tumors is associated with enrichment of alpha-smooth muscle actin-positive fibrosis and COMP-expressing stromal cells.
Graf SD; Keber CU; Hattesohl A; Teply-Szymanski J; Hattesohl S; Guder M; Gercke N; Di Fazio P; Slater EP; Jesinghaus M; Denkert C; Bartsch DK; Lehman B
J Neuroendocrinol; 2024 Feb; 36(2):e13364. PubMed ID: 38246597
[TBL] [Abstract][Full Text] [Related]
7. Mesenteric Fibrosis in Midgut Neuroendocrine Tumors: Functionality and Radiological Features.
Rodríguez Laval V; Pavel M; Steffen IG; Baur AD; Dilz LM; Fischer C; Detjen K; Prasad V; Pascher A; Geisel D; Denecke T
Neuroendocrinology; 2018; 106(2):139-147. PubMed ID: 28384635
[TBL] [Abstract][Full Text] [Related]
8. What Causes Desmoplastic Reaction in Small Intestinal Neuroendocrine Neoplasms?
Ratnayake GM; Laskaratos FM; Mandair D; Caplin ME; Rombouts K; Toumpanakis C
Curr Oncol Rep; 2022 Oct; 24(10):1281-1286. PubMed ID: 35554845
[TBL] [Abstract][Full Text] [Related]
9. Mesenteric fibrosis and palliative surgery in small intestinal neuroendocrine tumours.
Blažević A; Zandee WT; Franssen GJH; Hofland J; van Velthuysen MF; Hofland LJ; Feelders RA; de Herder WW
Endocr Relat Cancer; 2018 Mar; 25(3):245-254. PubMed ID: 29255095
[TBL] [Abstract][Full Text] [Related]
10. Molecular Genomic Assessment Using a Blood-based mRNA Signature (NETest) is Cost-effective and Predicts Neuroendocrine Tumor Recurrence With 94% Accuracy.
Modlin IM; Kidd M; Frilling A; Falconi M; Filosso PL; Malczewska A; Kitz A
Ann Surg; 2021 Sep; 274(3):481-490. PubMed ID: 34183517
[TBL] [Abstract][Full Text] [Related]
11. Circulating Neuroendocrine Gene Transcripts (NETest): A Postoperative Strategy for Early Identification of the Efficacy of Radical Surgery for Pancreatic Neuroendocrine Tumors.
Partelli S; Andreasi V; Muffatti F; Schiavo Lena M; Falconi M
Ann Surg Oncol; 2020 Oct; 27(10):3928-3936. PubMed ID: 32253675
[TBL] [Abstract][Full Text] [Related]
12. The NETest liquid biopsy is diagnostic for gastric neuroendocrine tumors: observations on the blood-based identification of microscopic and macroscopic residual diseaseOK.
Malczewska A; Procner A; Walter A; Kusnierz K; Zajecki W; Aslanian H; Kos-Kudla B
BMC Gastroenterol; 2020 Jul; 20(1):235. PubMed ID: 32703157
[TBL] [Abstract][Full Text] [Related]
13. Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest).
Modlin IM; Kidd M; Oberg K; Falconi M; Filosso PL; Frilling A; Malczewska A; Salem R; Toumpanakis C; Laskaratos FM; Partelli S; Roffinella M; von Arx C; Kudla BK; Bodei L; Drozdov IA; Kitz A
Ann Surg Oncol; 2021 Nov; 28(12):7506-7517. PubMed ID: 34008138
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Factors for Survival among Patients with Small Bowel Neuroendocrine Tumours Associated with Mesenteric Desmoplasia.
Laskaratos FM; Diamantopoulos L; Walker M; Walton H; Khalifa M; El-Khouly F; Koffas A; Demetriou G; Caplin M; Toumpanakis C; Mandair D
Neuroendocrinology; 2018; 106(4):366-380. PubMed ID: 29320779
[TBL] [Abstract][Full Text] [Related]
15. PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest.
Bodei L; Kidd MS; Singh A; van der Zwan WA; Severi S; Drozdov IA; Malczewska A; Baum RP; Kwekkeboom DJ; Paganelli G; Krenning EP; Modlin IM
Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):895-906. PubMed ID: 31838581
[TBL] [Abstract][Full Text] [Related]
16. Predicting resectability of primary tumor and mesenteric lymph-node masses in patients with small-intestine neuroendocrine tumors.
Bertani E; Zugni F; Radice D; Spada F; Bonomo G; Fumagalli Romario U; Fazio N; Funicelli L
Updates Surg; 2022 Oct; 74(5):1697-1704. PubMed ID: 35224681
[TBL] [Abstract][Full Text] [Related]
17. Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study.
van Treijen MJC; Korse CM; van Leeuwaarde RS; Saveur LJ; Vriens MR; Verbeek WHM; Tesselaar MET; Valk GD
Front Endocrinol (Lausanne); 2018; 9():740. PubMed ID: 30564197
[No Abstract] [Full Text] [Related]
18. Measurement of circulating transcript levels (NETest) to detect disease recurrence and improve follow-up after curative surgical resection of well-differentiated pancreatic neuroendocrine tumors.
Genç CG; Jilesen APJ; Nieveen van Dijkum EJM; Klümpen HJ; van Eijck CHJ; Drozdov I; Malczewska A; Kidd M; Modlin I
J Surg Oncol; 2018 Jul; 118(1):37-48. PubMed ID: 30114319
[TBL] [Abstract][Full Text] [Related]
19. Blood measurement of neuroendocrine gene transcripts defines the effectiveness of operative resection and ablation strategies.
Modlin IM; Frilling A; Salem RR; Alaimo D; Drymousis P; Wasan HS; Callahan S; Faiz O; Weng L; Teixeira N; Bodei L; Drozdov I; Kidd M
Surgery; 2016 Jan; 159(1):336-47. PubMed ID: 26456125
[TBL] [Abstract][Full Text] [Related]
20. The clinical utility of a novel blood-based multi-transcriptome assay for the diagnosis of neuroendocrine tumors of the gastrointestinal tract.
Modlin IM; Kidd M; Bodei L; Drozdov I; Aslanian H
Am J Gastroenterol; 2015 Aug; 110(8):1223-32. PubMed ID: 26032155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
